Oliver Illini

Medical University of Vienna

Austria

Research Interests

Explore related searches

Professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (7)

Nicole Heinzl

Medical University of Vienna

AUSTRIA

View details

Alfredo Addeo

University Hospital of Geneva

SWITZERLAND

View details

Robert Zeillinger

Lab head / Assoc. Professor

Medical University of Vienna

AUSTRIA

View details

Ralf Harun Zwick

Head of Department Cardiopulmonary Rehabilitation

AUSTRIA

View details

Eva Obermayr

Medical University of Vienna

AUSTRIA

View details

Stefan Watzka

Provisional Chairman/Associate Professor of Surgery

AUSTRIA

View details

Helmut Prosch

Assoc. Prof.

Medical University of Vienna

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Oliver Illini

Research Interests

Explore related searches

Contact this professor

Articles (9)

Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis

Complete Remission to Afatinib in a Patient Harboring a Novel Epidermal Growth Factor Mutation in De Novo Small-Cell Lung Cancer: A Case Report

Multimodal Treatment of Malignant Pleural Mesothelioma: Real-World Experience with 112 Patients

Effectiveness of Outpatient Pulmonary Rehabilitation in Patients with Surgically Resected Lung Cancer: A Retrospective Real-World Analysis

Characteristics and Treatment Outcomes in Advanced-Stage Non-Small Cell Lung Cancer Patients with a KRAS G12C Mutation: A Real-World Study

Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program

Cancer Stem Cell-Like Circulating Tumor Cells Are Prognostic in Non-Small Cell Lung Cancer

Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program

Later-Line Treatment with Lorlatinib in <i>ALK</i>- and <i>ROS1</i>-Rearrangement-Positive NSCLC: A Retrospective, Multicenter Analysis

Collaborators (7)

Nicole Heinzl

Alfredo Addeo

Robert Zeillinger

Ralf Harun Zwick

Eva Obermayr

Stefan Watzka

Helmut Prosch

Make your next move.